US Defense Secretary orders mandatory annual testosterone testing for soldiers aged 30 and above
The US Department of Defense will introduce mandatory annual testosterone testing for soldiers aged 30 and above, starting immediately. The announcement was made by US Defense Secretary Pete Hegseth on the platform X on Wednesday.
Hegseth stated that the goal of the testing is to ensure that soldiers have the optimal testosterone levels necessary for peak performance and long-term health. "It is a sacred duty to preserve the greatest tactical advantage of the USA: the individual fighter," Hegseth said in his announcement. He emphasized that the testing is about restoring and optimizing natural abilities, not artificially enhancing performance.
The testing will be part of the annual health exams for all active-duty and reserve military personnel aged 30 and above. For those under 30, the testing will be optional. If a soldier is found to have low testosterone levels, treatment will be recommended but not mandatory.
Hegseth's announcement has sparked political reactions. Democratic Senator Tammy Duckworth, a veteran of the Iraq War, questioned the focus on testosterone testing and suggested it might be a form of gender-affirming care. "This sounds like gender-affirming care," Duckworth said. Similarly, Congresswoman Summer Lee also questioned the motivation behind the testing.
The Pentagon has not specified whether the testing will apply to female soldiers, whose testosterone levels also decline with age. When asked about potential estrogen therapy for women experiencing perimenopause, Pentagon officials declined to comment.
Hegseth has been a proponent of traditional masculinity and has previously introduced policies banning transgender individuals from serving in the military. The new testosterone testing policy is seen as another step in his efforts to shape the military according to his vision of the male warrior.
The policy comes after previous statements by members of the Trump administration, including Health Secretary Robert F. Kennedy Jr., advocating for easier access to testosterone replacement therapy for men.
Follow us for live European news
- 4
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
3 further sources not geolocated



,xPosition=.5,yPosition=.5;Resize=(1200,675)&impolicy=medium)

